Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease

NCT04959578 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Anemia of Chronic Kidney Disease

Interventions

DRUG: Recombinant human erythropoietin
DRUG: Darbepoetin Alfa

Sponsor

Rufaida Mazahir